SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.130+0.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BoredMember who wrote (10195)5/8/2018 12:52:28 PM
From: drkaz  Read Replies (1) of 12873
 
There is scientific and engineering success and progress,... and there is corporate and financial success and progress.

I would love to see the science end of this business partnership achieve success, and it can be argued that there has been success on the tech end of the arrangement. The drug candidates produced to date certainly do appear to work splendidly in animal models.

However, H2F and others have pointed out, there has been no business or financial 'success' to date for anything other than TheraCour and it's direct owners. That ain't us.

I have bought into this company because I liked the science, but mostly because I thought that they were likely to break out and make a profit in the long-term. I've been here myself, with my own money, for about 8 years now. And NNVC is looking like it has painted itself into a corner. It's going to get a bit worse in the very near future for us when the next bit of capital is needed,... but I had hoped that the next raise would have some momentum behind it.

That does not appear to be the case.

That is the reality of the situation we find ourselves in, until or unless Dr. Diwan does something to change that fact.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext